[ad_1]
MatOrtho, a UK-based medical device manufacturer specializing in orthopedic implants, has achieved a significant regulatory milestone with its ReCerf® ceramic hip resurfacing system, which recently received CE Mark certification. This approval confirms the device meets stringent European safety and performance requirements, facilitating broader distribution across Europe and other regions that recognize CE standards.
MatOrtho’s ReCerf® ceramic hip resurfacing system represents a notable advancement in the field as it is the first commercially available all-ceramic implant. Its material composition addresses historical concerns linked to metal-on-metal alternatives while preserving more of the patient’s natural bone structure.
Since its initial clinical use in 2018 and subsequent approval by Australia’s Therapeutic Goods Administration in 2024, over 1,600 patients have received the implant, with early data indicating favorable patient outcomes and a low revision rate.
Image Credit: MatOrtho
[ad_2]
Source link